bpc-157 safety human trials bpc157 #peptide #unapproved | Mark Willis bpc 157 human safety clinical

Additionally, it displays anti-inflammatory properties, which can aid in reducing pain and swelling associated with these conditions

Updated: Jul

However, the drug is not without drawbacks

Administration approaches differ between the peptides

10 mg Vial Reconstitution BAC water added 2 mL Concentration 5,000 mcg/mL 250 mcg dose volume 0.05 mL = 5 units 500 mcg dose volume 0.10 mL = 10 units Doses per vial at 250 mcg 40 BAC water added 3 mL Concentration 3,333 mcg/mL 250 mcg dose volume 0.075 mL = ~7.5 units 500 mcg dose volume 0.15 mL = 15 units Doses per vial at 250 mcg 40 Units shown are U-100 insulin syringe units (where 100 units = 1.0 mL)